11.01.2024
ASH 2023 | Improving long-term outcomes with intensive chemotherapy in AML: looking to the future
Christoph Röllig, MD, MSc, Dresden University of Technology, Dresden, Germany, summarizes an education session delivered at the ASH 2023 meeting, which explored how to improve long-term outcomes with intensive...
Quelle: vjhemonc.com